Identification of two novel inhibitors of mTOR signaling pathway based on high content screening

Author： Yan Juming   Zhou Hongyu   Kong Lingmei   Zhang Jing   Zhao Qinshi   Li Yan  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.4, 2013-10, pp. : 799-808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

NRSF/REST regulates the mTOR signaling pathway in oral cancer cells

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1459-1464

Spandidos Publications

Access to resources Recommend Favorite

Updates of mTOR Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Quinoline Based Second-generation mTOR Inhibitor that Induces Apoptosis and Disrupts PI3K-Akt-mTOR Signaling in Human Leukemia HL-60 Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 10, 2015-12 ,pp. : 1297-1304

Bentham Science Publishers

Access to resources Recommend Favorite

Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma

By              

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 537-542

Spandidos Publications

Access to resources Recommend Favorite

Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway

By          

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1873-1878

Spandidos Publications

Access to resources Recommend Favorite